Frequencies for first 10,000 rows of drug7cl1 variable in nhamcsopd2005 dataset : ndc code #1 for medication #7 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, unspecified | 2 0.02 0.02 anesthetics, local (injectable) | 1 0.01 0.03 anesthetics, general | 2 0.02 0.05 anesthetics, topical | 2 0.02 0.07 anesthetics, rectal | 1 0.01 0.08 penicillins | 2 0.02 0.10 cephalosporins | 2 0.02 0.12 erythromycins/lincosamides/macrolides | 2 0.02 0.14 tetracyclines | 3 0.03 0.17 urinary tract antiseptics | 2 0.02 0.19 miscellaneous antibacterial agents | 4 0.04 0.23 quinolones/derivatives | 1 0.01 0.24 antiviral agents | 5 0.05 0.29 deficiency anemias | 11 0.11 0.40 anticoagulants/thrombolytics | 11 0.11 0.51 cardiac glycosides | 1 0.01 0.52 antianginal agents | 6 0.06 0.58 vascular disorders, cerebral/peripheral | 4 0.04 0.62 agents used to treat shock/hypotension | 1 0.01 0.63 antihypertensive agents | 20 0.20 0.83 diuretics | 29 0.29 1.12 relaxants/stimulants, urinary tract | 1 0.01 1.13 calcium channel blockers | 13 0.13 1.26 beta blockers | 18 0.18 1.44 alpha agonist/alpha blockers | 3 0.03 1.47 ace inhibitors | 22 0.22 1.69 sedatives and hypnotics | 12 0.12 1.81 antianxiety agents | 10 0.10 1.91 antipsychotic/antimanics | 10 0.10 2.01 antidepressants | 25 0.25 2.26 anorexiants/cns stimulants | 1 0.01 2.27 cns, miscellaneous | 1 0.01 2.28 alzheimer-type dementia | 1 0.01 2.29 disorders, acid/peptic | 27 0.27 2.56 antidiarrheals | 2 0.02 2.58 laxatives | 9 0.09 2.67 miscellaneous gastrointestinals | 2 0.02 2.69 antispasmodics/anticholinergics | 1 0.01 2.70 antacids | 6 0.06 2.76 metabolic and nurtient agents, unspec.. | 2 0.02 2.78 hyperlipidemia | 39 0.39 3.17 vitamins/minerals | 19 0.19 3.36 nutrition, enteral/parenteral | 1 0.01 3.37 repl/regs of electrolytes/water balance | 14 0.14 3.51 calcium metabolism | 7 0.07 3.58 hematopoietic growth factor | 2 0.02 3.60 adrenal corticosteroids | 7 0.07 3.67 estrogens/progestins | 4 0.04 3.71 anterior pituitary/hypothalamic functio | 1 0.01 3.72 blood glucose regulators | 39 0.39 4.11 thyroid/antithyroid | 9 0.09 4.20 contraceptives | 1 0.01 4.21 vaccines/antisera | 8 0.08 4.29 immunomodulators | 1 0.01 4.30 dermatologics, misc. | 4 0.04 4.34 topical steroids | 3 0.03 4.37 topical anti-infectives | 4 0.04 4.41 extrapyramidal movement disorders | 3 0.03 4.44 skeletal muscle hyperactivity | 5 0.05 4.49 anticonvulsants | 10 0.10 4.59 antineoplastics, miscellaneous | 1 0.01 4.60 hormonal/biological response mod. | 2 0.02 4.62 dna damaging drugs | 1 0.01 4.63 glaucoma | 3 0.03 4.66 vertigo/motion sickness/vomiting | 5 0.05 4.71 analgesics/general | 1 0.01 4.72 analgesics, narcotic | 31 0.31 5.03 analgesics, non-narcotic | 43 0.43 5.46 antimigraine/other headaches | 1 0.01 5.47 antiarthritics | 8 0.08 5.55 antigout | 2 0.02 5.57 nsaid | 8 0.08 5.65 antiprotozoals | 1 0.01 5.66 antimalarials | 1 0.01 5.67 antiasthmatics/bronchodilators | 28 0.28 5.95 nasal decongestants | 2 0.02 5.97 antitussives/expectorants/mucolytics | 2 0.02 5.99 antihistamines | 14 0.14 6.13 corticosteroid-inhalation/nasal | 4 0.04 6.17 miscellaneous/unclassified | 1 0.01 6.18 unclassified | 5 0.05 6.23 homeopathic products | 1 0.01 6.24 . | 9,376 93.76 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016